Influence of Intracerebroventricular Kallikrein and Lys-bradykinin on the Rabbit Renal Function.
- Author:
Jeong Tae KOH
1
;
Eun Kyung CHUNG
;
Young Chai LIM
;
Kyung Keun KIM
;
Young Johng KOOK
Author Information
1. Department of Pharmacology, College of Medicine, Chonnam National University, Kwangju, Korea.
- Publication Type:Original Article
- Keywords:
Renal Function;
Intracerebroventricular;
Kallikrein;
Lys-bradykinin;
Atrial Natriuretic Peptide(ANP)
- MeSH:
Atrial Natriuretic Factor;
Blood Pressure;
Brain;
Central Nervous System;
Diuresis;
Filtration;
Hemodynamics;
Hypotension;
Kallidin*;
Kallikreins*;
Natriuresis;
Natriuretic Agents;
Neurotransmitter Agents;
Plasma;
Renal Circulation;
Sodium;
Water
- From:Korean Journal of Nephrology
1999;18(2):219-229
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The renal function is under regulatory influence of central nervous system, in which various neurotransmitter and neuromodulator systems take part, and it has been known that kallikrein-kininogen- kinin system exists also in the brain, but its physiological role remains to be explored. This study was, therefore, undertaken to delineate the possible role of central kinin system in the regulation of renal function. Kallikrein given into a lateral ventricle(icv) of rabbit brain in doses ranging from 3 to 30 microgram/kg icv elicited increases in Na excretion and the fraction of filtered sodium excreted(FENa), as well as in urine flow rate. K excretion, however, did not parallel the Na excretion, but tended to decrease when the natriuresis reached its peak. Renal blood flow and glomerular filtration did not significantly change. Neither did free water reabsorption significantly change, but tended to decrease. The systemic blood pressure slightly increased. When 30 microgram/kg kallikrein was given intravenously, all the parameters of renal function and systemic blood pressure did not show any increase but decrease, primarily by decreased renal hemodynamics, resulting from transient hypotension. In experiments in which the plasma ANP was measured, the ANP level markedly increased, reaching more than 5 times the control value 25min after 30 microgram/kg icv, and lasting until the end of the experiment at 80min. The renal nerve activity increased with kallikrein, 30 microgram/kg icv, peaking at 1 min but it remained slightly increased until about 40 min, and then slightly declined. This indicates that the increased renal nerve activity may have antagonized or ameliorated the natriuretic effect of icv kallikrein. Lys-bradykinin(kallidin), a cleavage product from kallidinogen by kallikrein, when given icv in doses of 0.3 to 30 microgram/kg also produced increased Na excretion and diuresis. When CHA, a kallikrein inhibitor, was given icv in doses of 3-30 microgram/kg, elicited antidiuresis and antinatriuresis. However, pretreatment with CHA tended slightly to suppress the kallikrein effect. These results indicate that the central kallikrein- kinin system is involved in the central regulation of renal function, the activation of the system in the CNS resulting in increased natriuresis and diuresis, which are related to increased plasma ANP level, with the possible antagonistic effects of increased renal nerve activity.
